Suramya Waidyanatha

Suramya Waidyanatha

Auto-generated profile, based on publicly available information

Suramya Waidyanatha

National Institute of Environmental Health Sciences, NIH, 111 T.W. Alexander Drive, P.O. Box 12233, Research Triangle Park, NC, USA 27709

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2020 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
SWSuramya Waidyanatha
Suramya Waidyanatha
JPJessica Pierfelice
Jessica Pierfelice
TCTim Cristy
Tim Cristy
EMEsra Mutlu
Esra Mutlu
BBBrian Burback
Brian Burback
KRKristen Ryan
Kristen Ryan

1 July 2018 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
SWSuramya Waidyanatha
Suramya Waidyanatha
SBSherry R. Black
Sherry R. Black
RSRodney W. Snyder
Rodney W. Snyder
YYYun Lan Yueh
Yun Lan Yueh
VSVicki Sutherland
Vicki Sutherland
TFTimothy Raymond Fennell
Timothy Raymond Fennell

1 June 2019 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
SWSuramya Waidyanatha
Suramya Waidyanatha
SBSherry R. Black
Sherry R. Black
KAKristin Aillon
Kristin Aillon
BCBrad Collins
Brad Collins
PPPurvi R. Patel
Purvi R. Patel
TFTimothy Raymond Fennell
Timothy Raymond Fennell

31 August 2020 in Analytical and Bioanalytical Chemistry
Verified
Journal Article
Open access
PDF file
BCBradley J. Collins
Bradley J. Collins
SKSeason P. Kerns
Season P. Kerns
KAKristin Aillon
Kristin Aillon
GMGeoffrey Mueller
Geoffrey Mueller
Cynthia RiderCynthia Rider
Cynthia Rider
SWSuramya Waidyanatha
Suramya Waidyanatha
Ginkgo biloba extract (GbE) is a dietary supplement derived from an ethanolic extract of Ginkgo biloba leaves. Unfinished bulk GbE is used to make finished products that are sold as dietary supplements. The variable, complex composition of GbE makes it difficult to obtain consistent toxicological assessments of potential risk. The National Toxicology Program (NTP) observed hepatotoxicity in its rodent studies of a commercially available, unfinished GbE product, but the application of these results to the broader GbE supplement market is unclear. Here, we use a combination of non-targeted and targeted chromatographic and spectrophotometric methods to obtain profiles of 24 commercially available finished GbE products and unfinished standardized and unstandardized extracts with and without hydrolysis, then used principal component analysis to group unfinished products according to their similarity to each other and to National Institute of Standards and Technology (NIST) standard reference materials (SRM), and the finished products. Unfinished products were grouped into those that were characteristic and uncharacteristic of standardized GbE. Our work demonstrates that different analytical approaches produced similar classifications of characteristic and uncharacteristic products in unhydrolyzed samples, but the distinctions largely disappeared once the samples were hydrolyzed. Using our approach, the NTP GbE was most similar to two unfinished GbE products classified as characteristic, finished products, and the NIST GbE SRM. We propose that a simple analysis for the presence, absence, or amounts of compounds unique to GbE in unhydrolyzed samples could be sufficient to determine a sample’s authenticity.Graphical abstract

10 October 2016 in Environmental Science and Pollution Research
Verified
Journal Article
Closed access
PDF file
EMEsra Mutlu
Esra Mutlu
TCTim Cristy
Tim Cristy
SGSteven W. Graves
Steven W. Graves
MHMichelle J. Hooth
Michelle J. Hooth
SWSuramya Waidyanatha
Suramya Waidyanatha

31 December 2024 in Chemical Research in Toxicology
Verified
Journal Article
Open access
ARAnn M. Richard
Ann M. Richard
DTDingyin Tao
Dingyin Tao
CLChristopher LeClair
Christopher LeClair
WLWilliam Leister
William Leister
KTKirill V. Tretyakov
Kirill V. Tretyakov
RHRuili Huang
Ruili Huang
The analytical quality of compounds subjected to high-throughput screening (HTS) impacts accurate interpretation of assay results, with poor quality samples potentially leading to false negatives or positives. The Tox21 "10K" library consists of over 8900 unique compounds, spanning a diverse landscape of environmental and pharmaceutical chemicals, posing opportunities and challenges for analytical quality control (QC) determinations. Tox21 sample plates stored in DMSO at ambient conditions for 0 (T0) and/or 4 months (T4), totaling more than 13K unique sample identifiers (Tox21 IDs), were subjected to various analyses, including liquid and gas chromatography mass spectrometry (LC-MS, GC-MS) and nuclear magnetic resonance (NMR). Results for each sample at T0 or T4 underwent expert review and, where possible, a QC grade conveying purity, identity, and concentration was assigned. Herein, we relate details of the methods applied and report on the original (v0) Tox21 ID level results. Thirteen QC grades were condensed to 5 quality scores to aid global analysis, resulting in reinterpretation and improvement of >700 sample grades. Of the 92% T0 samples successfully graded, 76% exceeded 90% purity. For 76% of samples that were also tested at T4, 89% showed no evidence of sample loss or degradation. Prioritized quality bins were used to summarize thousands of replicate sample-level QC results to a compound-level QC score to support structure-based analyses. ToxPrint chemotype analysis identified structural features enriched in unstable compounds, as well as in high and low quality T0 subsets. Predicted vapor pressure was weakly correlated with low-concentration QC indicators, reflecting likely entanglement with method amenability and quality issues. Finally, an ongoing EPA effort to re-evaluate the original QC spectra is generating insights that will further modify QC grades. Tox21 QC spectra and results will be made available in a new public QC browser, facilitating further evaluation to support HTS interpretation and modeling applications.